WO2006124573A3 - Treatment of cancer with 2-deoxyglucose - Google Patents

Treatment of cancer with 2-deoxyglucose Download PDF

Info

Publication number
WO2006124573A3
WO2006124573A3 PCT/US2006/018404 US2006018404W WO2006124573A3 WO 2006124573 A3 WO2006124573 A3 WO 2006124573A3 US 2006018404 W US2006018404 W US 2006018404W WO 2006124573 A3 WO2006124573 A3 WO 2006124573A3
Authority
WO
WIPO (PCT)
Prior art keywords
deoxyglucose
cancer
treatment
administered
optionally
Prior art date
Application number
PCT/US2006/018404
Other languages
French (fr)
Other versions
WO2006124573A2 (en
Inventor
George Tidmarsh
Original Assignee
Threshold Pharmaceuticals Inc
George Tidmarsh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Threshold Pharmaceuticals Inc, George Tidmarsh filed Critical Threshold Pharmaceuticals Inc
Priority to JP2008511394A priority Critical patent/JP2008540566A/en
Publication of WO2006124573A2 publication Critical patent/WO2006124573A2/en
Publication of WO2006124573A3 publication Critical patent/WO2006124573A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
PCT/US2006/018404 2005-05-12 2006-05-12 Treatment of cancer with 2-deoxyglucose WO2006124573A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008511394A JP2008540566A (en) 2005-05-12 2006-05-12 Treatment of cancer with 2-deoxyglucose

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68070805P 2005-05-12 2005-05-12
US60/680,708 2005-05-12
US78730406P 2006-03-29 2006-03-29
US60/787,304 2006-03-29

Publications (2)

Publication Number Publication Date
WO2006124573A2 WO2006124573A2 (en) 2006-11-23
WO2006124573A3 true WO2006124573A3 (en) 2007-02-08

Family

ID=37431901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/018404 WO2006124573A2 (en) 2005-05-12 2006-05-12 Treatment of cancer with 2-deoxyglucose

Country Status (2)

Country Link
JP (1) JP2008540566A (en)
WO (1) WO2006124573A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022042B2 (en) * 2006-02-16 2011-09-20 Young Hee Ko Composition and methods for the treatment of cancer
GB0702446D0 (en) * 2007-02-08 2007-03-21 Sterix Ltd Composition
EP2129397B1 (en) * 2007-03-02 2018-10-31 Amgen, Inc. Methods and compositions for treating tumor diseases
EP2303282A4 (en) * 2008-05-23 2013-02-13 Univ Miami Treatment using continuous low dose application of sugar analogs
KR20200018634A (en) * 2017-06-28 2020-02-19 가부시키가이샤 센탄이료카이하츠 Pharmaceutical Compositions and Tumor Immune Activity Enhancers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose

Also Published As

Publication number Publication date
WO2006124573A2 (en) 2006-11-23
JP2008540566A (en) 2008-11-20

Similar Documents

Publication Publication Date Title
WO2004062604A3 (en) Treatment of cancer with 2-deoxyglucose
IL273765A (en) Combinations and modes of administration of therapeutic agents and combination therapy
WO2004064734A3 (en) Combination therapies for the treatment of cancer
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2009099634A3 (en) Picoplatin and amrubicin to treat lung cancer
WO2007050784A3 (en) Fixed ratio drug combination treatments for solid tumors
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
NZ544472A (en) Compounds and therapeutical use thereof
WO2004093831A3 (en) Cytokine-expressing cellular vaccine combinations
DK1169059T3 (en) Docetaxel in combination with rhuMAb HER2 for the treatment of cancers
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
EP1848418A4 (en) Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
IL155781A0 (en) Effective antitumor treatments
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2007134203A3 (en) Anticancer treatments with a combination of docetaxel and ecteinascidin
WO2006124573A3 (en) Treatment of cancer with 2-deoxyglucose
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2000040229A3 (en) Synergistic tumorcidal response induced by histamine
WO2011094260A3 (en) Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
IL159770A0 (en) Calcium salts with cytotoxic activity
WO2008079818A3 (en) Intravenous administration of water soluble analgesic formulations
WO2007103828A3 (en) Fluorocytidine derivatives and cox-2 inhibitors for the treatment of cancer
EP1374873B8 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
WO2007098183A3 (en) Treatment of cancer with 2-deoxygalactose

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008511394

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06759659

Country of ref document: EP

Kind code of ref document: A2